Differential susceptibilities to azithromycin treatment of chlamydial infection in the gastrointestinal tract and cervix

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 12, 2013, Pages 6290-6294

  Yeruva, Laxmi ^a   Melnyk, Stepan ^a   Spencer, Nicole ^a   Bowlin, Anne ^a   Rank, Roger G ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; CECUM; CHLAMYDIASIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; ELECTROCHEMICAL DETECTION; FEMALE; GASTROINTESTINAL INFECTION; GENITAL TRACT INFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVICITIS;

ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CERVIX UTERI; CHLAMYDIA INFECTIONS; FEMALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

EID: 84887436536     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01405-13     Document Type: Article

References (21)

1. Igietseme JU, Portis JL, Perry LL. 2001. Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae. Infect. Immun. 69:1832-1840.
2. Perry LL, Hughes S. 1999. Chlamydial colonization of multiple mucosae following infection by any mucosal route. Infect. Immun. 67:3686-3689.
3. Yeruva L, Spencer N, Bowlin AK, Wang Y, Rank RG. 2013. Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection. Pathog. Dis. 68:88-95.
4. Jones RB, Rabinovitch RA, Katz BP, Batteiger BE, Quinn TS, Terho P, Lapworth MA. 1985. Chlamydia trachomatis in the pharynx and rectum of heterosexual patients at risk for genital infection. Ann. Intern. Med. 102: 757-762.
5. Golden MR, Whittington WL, Handsfield HH, Hughes JP, Stamm WE, Hogben M, Clark A, Malinski C, Helmers JR, Thomas KK, Holmes KK. 2005. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N. Engl. J. Med. 352:676-685.
6. Batteiger BE, Tu W, Ofner S, Van der Pol B, Stothard DR, Orr DP, Katz BP, Fortenberry JD. 2010. Repeated Chlamydia trachomatis genital infections in adolescent women. J. Infect. Dis. 201:42-51.
7. Horner PJ. 2012. Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy. Sex. Transm. Infect. 88:154-156.
8. Drummond F, Ryder N, Wand H, Guy R, Read P, McNulty AM, Wray L, Donovan B. 2011. Is azithromycin adequate treatment for asymptomatic rectal chlamydia? Int. J. STD AIDS 22:478-480.
9. Hathorn E, Opie C, Goold P. 2012. What is the appropriate treatment for the management of rectal Chlamydia trachomatis in men and women? Sex. Transm. Infect. doi:10.1136/sextrans-2011-050466.
10. Barron AL, White HJ, Rank RG, Soloff BL, Moses EB. 1981. A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis. J. Infect. Dis. 143:63-66.
11. Hough AJ, Jr, Rank RG. 1988. Induction of arthritis in C57Bl/6 mice by chlamydial antigen: effect of prior immunization or infection. Am. J. Pathol. 130:163-172.
12. Beale AS, Upshon PA. 1994. Characteristics of murine model of genital infection with Chlamydia trachomatis and effects of therapy with tetracyclines, amoxicillin-clavulanic acid, or azithromycin. Antimicrob. Agents Chemother. 38:1937-1943.
13. Tabbara KF, al-Kharashi SA, al-Mansouri SM, al-Omar OM, Cooper H, el-Asrar AM, Foulds G. 1998. Ocular levels of azithromycin. Arch. Ophthalmol. 116:1625-1628.
14. Paul TR, Knight ST, Raulston JE, Wyrick PB. 1997. Delivery of azithromycin to Chlamydia trachomatis-infected polarized human endometrial epithelial cells by polymorphonuclear leucocytes. J. Antimicrob. Chemother. 39:623-630.
15. Schwebke JR, Rompalo A, Taylor S, Sena AC, Martin DH, Lopez LM, Lensing S, Lee JY. 2011. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens-A randomized clinical trial. Clin. Infect. Dis. 52:163-170.
16. Lau CY, Qureshi AK. 2002. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex. Transm. Dis. 29:497-502.
17. Martin DH, Mroczkowski TF, Dalu ZA, McCarty J, Jones RB, Hopkins SJ, Johnson RB. 1992. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. N. Engl. J. Med. 327:921-925.
18. Thorpe EMJ, Stamm WE, Hook EW, Gall SA, Jones RB, Henry K, Whitworth G, Johnson RB. 1996. Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practises. Genitourin. Med. 72:93-97.
19. Whittington WL, Kent C, Kissinger P, Oh MK, Fortenberry JD, Hillis SE, Litchfield B, Bolan GA, St Louis ME, Farley TA, Handsfield HH. 2001. Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex. Transm. Dis. 28:117-123.
20. Horner P. 2006. The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection. Sex Transm. Infect. 82:340-343.
21. Wang SA, Papp JR, Stamm WE, Peeling RW, Martin DH, Holmes KK. 2005. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J. Infect.Dis. 191:917-923.